AGP Executive Report
Last update: 6 minutes agoVape Crackdown: Malaysia’s health minister says vape seizures show liquids mixed with dangerous synthetics (including THC and cannabinoids), building the case for a national vape ban. Medical Research: University of Arizona researchers report cannabis-derived terpenes may ease chronic pain like fibromyalgia and post-surgical pain without THC’s high. Safety on the Illicit Market: Arizona State University finds low likelihood of fentanyl being added to seized illegal cannabis flower (none detected in 118 samples). Patient Outcomes: A UK registry study links cannabis-based medicinal products to meaningful pain reductions and fewer opioid use in Ehlers-Danlos/hypermobility patients. Industry Pressure: Nebraska hemp retailers push back against a proposed “zero THC” rule for food products, arguing it goes beyond federal limits and could wipe shelves. Enforcement & Supply Chain: Police in West Sussex seized 500+ cannabis plants; Cyprus police seized 6.37kg cannabis resin plus 1kg kief. Market & Policy: A Lancet review suggests the key question is how cannabis is regulated—profit-linked legalization correlates with higher use and addiction, not just “whether” to legalize. Retail Ops: Minnesota cannabis testing site shutdown is causing product delays for retailers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.